Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh T Packiam

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Expert Opinion on Pharmacotherapy|January 24, 2024
Combination intravesical chemotherapy for non-muscle invasive bladder cancer (NMIBC) as first-line or rescue therapy: where do we stand now?Mohamad Abou Chakra, Vignesh T Packiam, Igor Duquesne, et al.
Urology|November 29, 2016
The Effect of Obesity on Perioperative Outcomes for Open and Minimally Invasive ProstatectomyScott C Johnson, Vignesh T Packiam, Shay Golan, et al.
Urology|January 17, 2022
The Association of Trainee Involvement in Radical Cystectomy With Perioperative and Oncologic OutcomesMatvey Tsivian, Raevti Bole, Vignesh T Packiam, et al.
Urologic Oncology|October 7, 2023
Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinomaIan M McElree, Alex Belzer, Sarah L Mott, et al.
Urology|May 20, 2016
30-Day Morbidity and Reoperation Following Midurethral Sling: Analysis of 8772 Cases Using a National Prospective DatabaseAndrew J Cohen, Vignesh T Packiam, Charles U Nottingham, et al.
Urology|May 17, 2016
Iatrogenic Bladder Injury: National Analysis of 30-Day OutcomesAndrew J Cohen, Vignesh T Packiam, Charles U Nottingham, et al.
European Urology Focus|June 27, 2025
Extended Outcomes of Intravesical Valrubicin and Docetaxel as a Secondary Salvage Treatment for Recalcitrant High-risk Non-muscle-invasive Bladder CancerIan M McElree, Ryan L Steinberg, Helen Y Hougen, et al.
European Urology Oncology|June 4, 2019
Incidence, Risk Factors, and Outcomes for Rectal Injury During Radical Prostatectomy: A Population-based StudyNimrod S Barashi, Shane M Pearce, Andrew J Cohen, et al.
Urology|May 24, 2016
Open Vs Minimally Invasive Adult Ureteral Reimplantation: Analysis of 30-day Outcomes in the National Surgical Quality Improvement Program (NSQIP) DatabaseVignesh T Packiam, Andrew J Cohen, Charles U Nottingham, et al.
Urology|July 10, 2016
The Impact of Minimally Invasive Surgery on Major Iatrogenic Ureteral Injury and Subsequent Ureteral Repair During Hysterectomy: A National Analysis of Risk Factors and OutcomesVignesh T Packiam, Andrew J Cohen, Joseph J Pariser, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Expert Opinion on Pharmacotherapy|January 24, 2024
Combination intravesical chemotherapy for non-muscle invasive bladder cancer (NMIBC) as first-line or rescue therapy: where do we stand now?Mohamad Abou Chakra, Vignesh T Packiam, Igor Duquesne, et al.
Urology|November 29, 2016
The Effect of Obesity on Perioperative Outcomes for Open and Minimally Invasive ProstatectomyScott C Johnson, Vignesh T Packiam, Shay Golan, et al.
Urology|January 17, 2022
The Association of Trainee Involvement in Radical Cystectomy With Perioperative and Oncologic OutcomesMatvey Tsivian, Raevti Bole, Vignesh T Packiam, et al.
Urologic Oncology|October 7, 2023
Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinomaIan M McElree, Alex Belzer, Sarah L Mott, et al.
Urology|May 20, 2016
30-Day Morbidity and Reoperation Following Midurethral Sling: Analysis of 8772 Cases Using a National Prospective DatabaseAndrew J Cohen, Vignesh T Packiam, Charles U Nottingham, et al.
Urology|May 17, 2016
Iatrogenic Bladder Injury: National Analysis of 30-Day OutcomesAndrew J Cohen, Vignesh T Packiam, Charles U Nottingham, et al.
European Urology Focus|June 27, 2025
Extended Outcomes of Intravesical Valrubicin and Docetaxel as a Secondary Salvage Treatment for Recalcitrant High-risk Non-muscle-invasive Bladder CancerIan M McElree, Ryan L Steinberg, Helen Y Hougen, et al.
European Urology Oncology|June 4, 2019
Incidence, Risk Factors, and Outcomes for Rectal Injury During Radical Prostatectomy: A Population-based StudyNimrod S Barashi, Shane M Pearce, Andrew J Cohen, et al.
Urology|May 24, 2016
Open Vs Minimally Invasive Adult Ureteral Reimplantation: Analysis of 30-day Outcomes in the National Surgical Quality Improvement Program (NSQIP) DatabaseVignesh T Packiam, Andrew J Cohen, Charles U Nottingham, et al.
Urology|July 10, 2016
The Impact of Minimally Invasive Surgery on Major Iatrogenic Ureteral Injury and Subsequent Ureteral Repair During Hysterectomy: A National Analysis of Risk Factors and OutcomesVignesh T Packiam, Andrew J Cohen, Joseph J Pariser, et al.
Pageof 14